DNTH
Dianthus Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$77.86
-2.46 ▼ -3.06%
🌙 3월 13일 7:43 PM ET (한국 3/14 08:43)
$77.80
-0.06 ▼ -0.08%
| Index | RUT | P/E | - | EPS (ttm) | -4.11 | Insider Own | 16.67% | Shs Outstand | 0.04B | Perf Week | 19.42% |
| Market Cap | 3.46B | Forward P/E | - | EPS next Y | -11.35% | Insider Trans | -5.33% | Shs Float | 0.04B | Perf Month | 55.97% |
| Enterprise Value | 3.06B | PEG | - | EPS next Q | -1.06 | Inst Own | 102.29% | Short Float | 21.3% | Perf Quarter | 78.66% |
| Income | -0.16B | P/S | 1697.31 | EPS this Y | -1.25% | Inst Trans | 7.21% | Short Ratio | 8.25 | Perf Half Y | 105.65% |
| Sales | 0.00B | P/B | 6.82 | EPS next 5Y | -8.72% | ROA | -35.85% | Short Interest | 7.89M | Perf YTD | 88.93% |
| Book/sh | 11.42 | P/C | 8.56 | EPS past 3/5Y | 49.46% 31.21% | ROE | -38.38% | 52W High | -11.54% ($88.02) | Perf Year | 265.88% |
| Cash/sh | 9.09 | P/FCF | - | Sales past 3/5Y | -31.8% - | ROIC | -32.83% | 52W Low | 482.57% ($13.36) | Perf 3Y | 540.3% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -58.36% | Gross Margin | 78.98% | Volatility(W/M) | 8.91% 7.51% | Perf 5Y | -62.65% |
| Dividend TTM | - | EV/Sales | 1499.81 | Sales Y/Y TTM | -67.35% | Oper. Margin | -8739.34% | ATR (14) | 5.34 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 13.32 | EPS Q/Q | -76.48% | Profit Margin | -7973.33% | RSI (14) | 70.2 | Recom | 1.07 |
| Dividend Gr. 3/5Y | - | Current Ratio | 13.32 | Sales Q/Q | -78.58% | SMA20 | 27.79% ($60.93) | Beta | 1.37 | Target Price | $128.17 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | 48.83% ($52.31) | Rel Volume | 2.41 | Prev Close | $80.32 |
| Employees | 92 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -42.18% -48.57% | SMA200 | 119.16% ($35.53) | Avg Volume(3M) | 0.96M | Price | $77.86 |
| IPO | 2018/6/21 | Option/Short | Yes/Yes | Trades | 18007 | Volume | 2,300,961 | Change | -3.06% |
뉴스 로딩 중...